Transplantation in Parkinson's disease

Artificial Organs

Volumn 21, Issue 11, 1997, Pages 1199-1202

  Fink, J Stephen ^a,b  

^a GENVEC INC   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fetal cells; Parkinson's Disease; Porcine cells; Transplantation

Indexed keywords

GENE THERAPY;

CELLULARS; DEGENERATIVE DISEASE; FETAL CELLS; HETEROLOGOUS GENES; PARKINSON'S DISEASE; PORCINE CELL; SYSTEM FUNCTIONS; TRANSPLANTATION;

NEURODEGENERATIVE DISEASES;

ALLOGRAFT; BRAIN TRANSPLANTATION; CELL TRANSPLANTATION; CONFERENCE PAPER; MESENCEPHALON; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

SUIDAE;

EID: 0030779382     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1997.tb00475.x     Document Type: Conference Paper

References (30)

1. Tsui JKC, Calne DB. Treatment of Parkinson's disease; Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994: 573-82.
2. Calne DB. Treatment of Parkinson's disease. N Engl J Med 1993;329:1021-7.
3. Björklund A, Stenevi U. Reconstruction of the nigrostriatal pathway by intracerebral nigral transplants. Brain Res 1979; 177:555-60.
4. Perlow MJ, Freed WJ, Hoffer BJ, Seiger A, Olson L, Wyatt RJ. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Neurosurgery 1979;204:643-47.
5. Pakzaban P, Deacon TW, Burns LH, Dinsmore J, Isacson O. A novel mode of immunoprotection of neural xenotransplants: Masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 1995;65:983-96.
6. Brundin P, Strecker R, Widner H, Clarke D, Nilsson O, Astedt B, Lindvall O, Björklund A. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: Immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp Brain Res 1988;70:192-208.
7. Brundin P, Barbin G, Strecker R, Isacson O, Prochiantz A, Björklund A. Survival and function of dissociated rat dopamine neurons grafted at different developmental stages or after being cultured in vitro. Brain Res 1988;467:233-43.
8. Huffaker T, Boss B, Morgan A, Neff N, Strecker R, Spence M, Miao R. Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease. Exp Brain Res 1989;77:329-36.
9. Sanberg PR, Borlongan CV, Saporta S, Camerson DF. Testisderived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nature Biotechnol 1996; 14:1692-5.
10. Björklund A, Dunnett S, Stenevi U, Lewis M, Iverson S. Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing. Brain Res 1980;199: 307-33.
11. Isacson O, Deacon TW, Pakzaban P, Galpern WR, Dinsmore J, Burns LH. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nature Med 1995;11:1189-94.
12. Madrazo I, Drucker-Colin, Diaz V, Martinez-Mata J, Torres C, Becerril JJ. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. New Engl J Med 1987;316:831-3.
13. Lindvall O, Backlund EO, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Ann Neurol 1987;22:457-68.
14. Olanow CW, Kolle W, Goetz CG, Stebbins CT, Cahill DW, Gauger LL, Morantz R, Penn RD, Tanner CM, Klawans HL, Shannon KM, Comella CL, Eitt T. Autologous transplantation of adrenal medulla in Parkinson's disease. Arch Neurol 1990;47:1286-9.
15. Lindvall O, Rehncrona S, Gustuvii B, Brundin P, Astedt B, Widner H, Lindholm T, Bjorklund A, Leenders KL, Rothwell JC, Frackowiak R, Marsden CA, Johuels B, Steig G, Freedman R, Hoffer BJ, Seiger A, Stromberg I, Bygdeman M, Olsen L. Fetal dopamine-rich mesencephalic grafts in Parkinson's disease. Lancet 1988;2:1483-4.
16. Madrazo I, Leon V, Torres C, Aguilera MC, Verela C, Alvarez F, Fraga A, Drucker-Colin R, Ostrosky F, Skurovich M, Franco R. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson's disease. New Engl J Med 1988;318:51.
17. Spencer D, Robbins R, Naftolin F, Marek K, Vollmer T, Leranth C, Roth R, Price L, Gjedde A, Bunney B, Sass K, Elsworth J, Kier E, Makuch R, Hoffer P, Redmund D. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. New Engl J Med 1992;327:1541-8.
18. Freed C, Breeze R, Rosenberg N, Schneck S, Kriek E, Qi J, Lone T, Zhang Y, Snyder J, Wells T, Ramig L, Thompson L, Mazziotta J, Huang S, Grafton S, Brooks D, Sawle G, Schroter G, Ansari A. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. New Engl J Med 1992;237: 1549-55.
19. Freeman T, Olanow C, Hauser R, Nauert G, Smith D, Borlongan C, Sanherg P, Holt D, Kordower J, Vingerhoets F, Snow B, Calne D, Gauger L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995;38:379-88.
20. Defer G, Geny C, Ricolfi F, Fenelon G, Monfort J, Philippe R, Villafane G, Jeny R, Samson Y, Keravek Y, Gaston A, Degos J-D, Peschanski M, Cesaro P, Nguyen J-P. Long-term outcome of unilaterally transplanted parkinsonian patients I Clinical approach. Brain 1996;119:41-50.
21. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björkund A, Lindvall O, Langston W. Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). New Engl J Med 1992;237:1556-63.
22. Lindvall O, Sawle G, Widner H, Rothwell J, Björkund A, Brooks D, Brundin P, Frackowiak R, Marsden CD, Odin P, Rehncrona S. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann Neurol 1994;35:172-80.
23. Madrazo I, Franco-Bourland R, Aguilera M, Ostrosky-Solis F. Hispanic registry of graft procedures for Parkinson's disease. Lancet 1989;2:751-2.
24. Kordower JH, Freeman TB, Snow BJ, Vingerhoets JG, Mufson EJ, Sanherg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, Olanow CW. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl J Med 1995;332:1118-24.
25. Galpern WR, Burns LH, Deacon TW, Dinsmore J, Isacson O. Xenotransplantation of porcine fetal ventral mesencephalon in a rat model of Parkinson's disease: Functional recovery and graft morphology. Exp Neurol 1996;140:1-13.
26. Deacon T, Thomas C, Dinsmore J, Palmer EP, Penney D, Kott S, Dempsey P, Isacson O, Schumachcr J. Post-mortem histological characterization of surviving porcine mesemcephalic cell suspension xenografts in a parkinsonian patient. Soc Neurosci Abstr 1996;22:318.
27. Fahn S, Elton RL. Members of the UPDRS Development Committee. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park. NJ: Macmillan Healthcare Information, 1987:153-304.
28. Langston JW, Windner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core Assessment Program for Intracerebral Transplantation (CAPIT). Mov Disord 1992;7:2-13.
29. Guetz CG, Stebbins GT III, Klawans HL, Koller WC, Grossman RG, Bakay RA, Penn RD, the United Parkinson Foundation Neural Transplantation Registry. United Parkinson Foundation neurotransplantation registry on adrenal medullary transplants: Presurgical, and 1- and 2-year follow-up. Neurology 1991;41:1719-22.
30. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Bjorklund A, Brooks DJ, Marsden CD, Quinn N, Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997;42:95-107.